Recombinant Equine herpesvirus 1 Trans-acting transcriptional protein ICP4 (IE), partial

Shipped with Ice Packs
In Stock

Description

Introduction to Recombinant Equine Herpesvirus 1 Trans-Acting Transcriptional Protein ICP4 (IE), Partial

Equine Herpesvirus 1 (EHV-1) is a significant pathogen in horses, causing a range of diseases including rhinopneumonia, abortion, and myeloencephalitis . Within EHV-1, the infected cell protein 4 (ICP4) plays a crucial role in viral gene expression . ICP4, also known as IE protein, is an immediate-early (IE) phosphoprotein essential for activating transcription from viral early and late promoters and regulating transcription from its own promoter . Recombinant forms of EHV-1, such as the natural recombinant EHV-1 B strain, have emerged through genetic recombination between different herpesviruses, impacting the virus's characteristics and pathogenicity .

Genetic Structure and Function of ICP4

ICP4 is encoded by the ORF64 gene located within the EHV-1 genome . As an immediate-early (IE) gene, ICP4's expression does not require additional protein synthesis, making it a key regulator in the early stages of infection . The protein product, ICP4, functions as a transcriptional activator for early genes, controlling the cascade of viral gene expression necessary for replication . The EHV-1 IE protein of 1487 amino acids contains a serine-rich tract (SRT) between residues 181 and 220 .

Recombination Events Involving ICP4

Natural recombination events can occur between different equine herpesviruses, leading to the emergence of new viral strains with altered characteristics . For example, the EHV-1 B strain has been identified as a naturally occurring recombinant virus between progenitors of EHV-1 P and EHV-4 . In EHV-1 B, the 3'-end and downstream region of the ICP4 gene have been replaced by the corresponding region of EHV-4 . This interspecies recombination in alphaherpesviruses can result in changes in viral tropism, pathogenicity, and immune response .

Role of ICP4 in Viral Replication

ICP4 is essential for the activation of transcription from viral early and late promoters and regulates transcription from its own promoter . ICP4 plays a crucial role as a transcription activator for early genes .

Neuropathogenic Variants and ICP4

EHV-1 strains can be classified as either neuropathogenic or non-neuropathogenic based on their genetic characteristics and clinical presentation . Neuropathogenic variants, such as those with the G2254/D752 genotype, have been associated with increased incidence of equine herpesvirus neurologic disease . While ICP4 itself is not the sole determinant of neuropathogenicity, its interaction with other viral and host factors may contribute to the development of neurological symptoms .

ICP4 as a Target for Vaccine Development

Given its essential role in viral replication and transcription, ICP4 has been explored as a potential target for vaccine development and antiviral strategies . EHV-1 has potential as a vaccine vector because it can efficiently transduce a variety of animal and human cells . Immunization strategies targeting ICP4 or its regulatory pathways may offer opportunities for controlling EHV-1 infections and reducing disease severity .

Tables

Table 1: Key Features of EHV-1 ICP4

FeatureDescription
GeneORF64
FunctionTranscriptional activator, regulator of viral gene expression
ExpressionImmediate-early (IE)
ImportanceEssential for viral replication and pathogenesis
Recombinant FormsEHV-1 B strain with ICP4 gene region replaced by EHV-4
Interaction with VP22VP22 promotes ICP4 synthesis post-transcriptionally
Neuropathogenic StrainsG2254/D752 genotype associated with increased neurologic disease; ICP4's interaction with other factors may contribute
Vaccine TargetPotential target for vaccine development and antiviral strategies

Product Specs

Form
Lyophilized powder

Note: While we prioritize shipping the format currently in stock, please specify any format requirements in your order notes for customized fulfillment.

Lead Time
Delivery times vary depending on the purchase method and location. Please contact your local distributor for precise delivery estimates.

Note: Standard shipping includes blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.

Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Before opening, briefly centrifuge the vial to collect the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50% and may serve as a reference.
Shelf Life
Shelf life depends on various factors including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is recommended for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during the manufacturing process.

The tag type is determined during production. If you require a specific tag, please inform us, and we will prioritize its inclusion.

Synonyms
IE; 64; Major viral transcription factor ICP4 homolog; 155 kDa immediate-early protein
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Protein Length
partial
Purity
>85% (SDS-PAGE)
Species
Equine herpesvirus 1 (strain V592) (EHV-1) (Equine abortion virus)
Target Names
IE
Uniprot No.

Target Background

Function

This IE protein is a multifunctional protein with the capacity for nuclear translocation, DNA binding, trans-activation of other viral genes, and autoregulation of its own synthesis.

Protein Families
Herpesviridae ICP4 family
Subcellular Location
Host nucleus.

Q&A

What is the ICP4 protein and what is its role in EHV-1?

ICP4 (Infected Cell Protein 4) is an immediate early (IE) protein that functions as a major transcriptional regulator in Equine herpesvirus 1. It is encoded by ORF64, a double-copy gene located within the repeat regions of the viral genome . As a transcription factor, ICP4 plays multiple essential roles during viral infection including: regulation of the transcriptional cascade, coating the viral genome, and assisting in the circularization of the herpes genome . ICP4 serves as both an activator and repressor of viral and host genes, making it critical for the proper temporal expression of viral genes throughout the replication cycle . Without ICP4, the virus cannot properly progress from immediate early gene expression to early and late gene expression phases, severely impairing viral replication.

How is ICP4 structurally organized and what are its functional domains?

ICP4 contains several functional domains that contribute to its regulatory activities. The protein includes:

  • A DNA binding domain (DBD) that enables interaction with specific viral DNA sequences

  • A C-terminal activation (CTA) domain that enhances DNA binding affinity

  • An N-terminal activation domain that mediates interactions with cellular transcription factors, particularly TFIID and mediator complexes

The DNA binding capability of ICP4 is most crucial for interactions with immediate early (IE) promoters, although its sequence specificity varies throughout viral replication . The protein can oligomerize on DNA when both the DBD and CTA domains are present, which may increase DNA affinity or specificity for early (E) or late (L) genes . These structural features allow ICP4 to modify its binding characteristics throughout the infection cycle, enabling precise temporal regulation of viral gene expression.

How is ICP4 expression regulated in EHV-1?

ICP4 expression is regulated at multiple levels during viral infection. As an immediate early gene product, ICP4 is among the first viral proteins synthesized following infection. The expression of ICP4 appears to be influenced by viral tegument proteins, particularly VP22. Research has shown that deletion of VP22 leads to decreased expression of ICP4 protein, despite unchanged mRNA levels, suggesting VP22 promotes ICP4 synthesis post-transcriptionally . This indicates complex post-transcriptional regulation mechanisms controlling ICP4 protein levels.

Additionally, ICP4 is subject to feedback regulation. Once expressed, ICP4 can repress its own promoter while activating early and late viral genes, creating a regulatory circuit that controls viral gene expression temporally . This auto-regulatory mechanism helps transition the virus from the immediate early phase to subsequent phases of replication.

What recombination patterns have been identified in the ICP4 gene of equid herpesviruses?

Multiple recombination events involving the ICP4 gene have been documented among equid herpesviruses. Comprehensive analysis has identified 14 recombination events between various equid alphaherpesvirus species, with 10 of these events directly involving ORF64, which encodes ICP4 . Specific recombination patterns include:

  • EHV-1 × EHV-4 recombination: This includes natural recombinants where the 3'-end and downstream region of the ICP4 gene in EHV-1 B has been replaced by the corresponding region from EHV-4 . This represents the first documented natural interspecies recombinant in alphaherpesviruses.

  • EHV-1 × EHV-9 recombination: These events particularly affect zebra-borne genotypes of EHV-1 that infect wild equids .

  • EHV-8 × EHV-9 recombination: Recombination has been identified in the EHV-8/IR/2010/47 strain within the ICP4 gene from positions 177-427 bp .

These findings strongly suggest that the ICP4 gene region serves as a hotspot for recombination among equid herpesviruses, potentially contributing to viral evolution and adaptation to different hosts .

What experimental approaches are recommended for studying ICP4 DNA-binding properties?

When investigating ICP4 DNA-binding properties, researchers should consider several experimental methodologies:

  • Crystallographic analysis: X-ray crystallography has been successfully used to determine the structure of ICP4 bound to DNA. This approach provides atomic-level resolution of the protein-DNA complex and reveals critical binding interfaces. For optimal results, researchers should consider using constructs containing both the DNA binding domain and removing intrinsically disordered regions to improve crystal formation .

Crystallography ParametersICP4NΔIDR·IE3_12merICP4N·IE3_19mer
Space groupP 2₁2₁2₁P 2₁2₁2₁
Cell dimensions (Å)127.3, 39.1, 90.461.5, 100.7, 201.9
Resolution (Å)45.22–2.1271.30–2.28
R merge0.120.16
I/σI9.498.69
Completeness (%)95100
  • Long and accurate PCR (LA-PCR) combined with restriction fragment length polymorphism (RFLP) analysis: This approach has proven effective for identifying differences in restriction sites focused in ORF64 (encoding ICP4) and regions downstream of the ICP4 gene . This method is particularly useful for studying recombination events.

  • DNA-protein binding assays: Electrophoretic mobility shift assays (EMSAs) can be employed to assess the affinity and specificity of ICP4 binding to different DNA sequences, including consensus and non-consensus sites.

  • Chromatin immunoprecipitation (ChIP): This technique allows for the identification of ICP4 binding sites across the viral genome during different stages of infection, providing insights into temporal regulation patterns.

How does ICP4 function differ between immediate early and later phases of infection?

ICP4 demonstrates distinct regulatory activities at different stages of viral infection:

  • Immediate early phase (1-1.5 hours post-infection):

    • Unexpectedly, ICP4 acts primarily as a repressor of transcriptional activity across viral genomes

    • In the absence of ICP4, high levels of aberrant transcriptional activity occur across mutant viral genomes

    • ICP4 decreases RNA polymerase activity on all viral genes during this phase

    • It establishes controlled gene expression by reducing total polymerase occupancy across entire genes rather than increasing polymerase pausing

  • Later phases (3-6 hours post-infection):

    • ICP4 transitions to its well-documented role as an activator of early and late gene expression

    • It increases RNA polymerase activity on early, late-late, and late gene classes

    • Simultaneously, it maintains repression of immediate early genes to prevent their overexpression

    • Failed repression of IE genes and promotion of later gene classes is a characteristic phenotype of ICP4 mutants

This biphasic regulatory pattern is critical for orchestrating the orderly progression of viral gene expression throughout the replication cycle. The initial repressive function at immediate early times was unexpected based on previous understandings of ICP4 function and suggests a more complex regulatory role than previously recognized .

What approaches can be used to detect and characterize recombination events in the ICP4 gene?

To effectively identify and characterize recombination events in the ICP4 gene, researchers should consider implementing a multi-faceted approach:

  • Computational recombination detection:

    • RDP4 software package: This comprehensive suite combines multiple recombination detection methods and has been successfully used to identify recombination events between equid alphaherpesviruses

    • Simplot analysis: This visualization tool helps identify potential breakpoints and recombination regions by comparing sequence similarity across viral genomes

    • Phylogenetic analysis: Constructing phylogenetic trees based on different regions of the ICP4 gene can reveal incongruent evolutionary histories, suggesting recombination

  • Molecular characterization:

    • Full genome sequencing: Next-generation sequencing of complete viral genomes provides the foundation for comprehensive recombination analysis

    • Long and accurate PCR (LA-PCR): This technique allows amplification of longer DNA fragments with high fidelity, enabling analysis of the extended ICP4 gene region

    • Restriction fragment length polymorphism (RFLP): Analysis of restriction patterns can identify differences in restriction sites focused in the ICP4 gene region

  • Experimental validation:

    • Cloning and expression of chimeric ICP4 proteins: This enables functional characterization of recombinant variants

    • Reporter assays: These can assess the transcriptional regulatory capabilities of different ICP4 variants

    • In vitro recombination studies: These can help determine the mechanistic basis for ICP4's role as a recombination hotspot

When applying these methods, researchers should pay particular attention to the repeat regions of the viral genome, as 10 out of 14 identified recombination events involved ORF64/ICP4 located in these regions .

What experimental designs are most effective for studying the post-transcriptional regulation of ICP4?

To investigate the post-transcriptional regulation of ICP4, particularly the role of tegument proteins like VP22, researchers should consider the following experimental approaches:

  • Viral mutant construction and analysis:

    • Generate VP22-deficient viruses using reverse genetics approaches

    • Compare ICP4 protein expression between wild-type and mutant viruses using Western blot analysis

    • Quantify ICP4 mRNA levels using real-time PCR to distinguish transcriptional from post-transcriptional effects

  • Protein-RNA interaction studies:

    • RNA immunoprecipitation (RIP) to identify protein factors that bind to ICP4 mRNA

    • RNA electrophoretic mobility shift assays (REMSAs) to assess direct binding of VP22 or other viral/cellular proteins to ICP4 mRNA

    • Mass spectrometry analysis to identify proteins associated with ICP4 mRNA ribonucleoprotein complexes

  • Translation efficiency analysis:

    • Polysome profiling to assess translation efficiency of ICP4 mRNA in the presence or absence of VP22

    • Ribosome profiling to determine ribosome occupancy on ICP4 mRNA under different conditions

    • In vitro translation assays to directly measure the impact of VP22 on ICP4 protein synthesis

  • RNA stability assessments:

    • Actinomycin D chase experiments to measure ICP4 mRNA half-life in cells infected with wild-type versus VP22-deficient viruses

    • Northern blot analysis to examine potential differences in ICP4 mRNA processing or integrity

Since research has demonstrated that VP22 deletion results in decreased ICP4 protein expression without affecting mRNA levels, these approaches would help elucidate the mechanisms by which VP22 promotes ICP4 synthesis post-transcriptionally .

What techniques are most suitable for analyzing ICP4's role in transcriptional regulation during viral infection?

To comprehensively investigate ICP4's dynamic role in transcriptional regulation during EHV-1 infection, researchers should consider these advanced methodological approaches:

  • Genome-wide transcriptional profiling:

    • Precision nuclear run-on sequencing (PRO-Seq): This technique provides high-resolution mapping of active RNA polymerase positions across the viral genome at different time points post-infection

    • Comparison between wild-type and ICP4-mutant viruses can reveal genome-wide regulatory impacts

    • Analysis of sense-to-antisense transcription ratios helps determine how ICP4 regulates directional transcription

  • Chromatin structure and protein-DNA interaction analysis:

    • Chromatin immunoprecipitation followed by sequencing (ChIP-seq): Maps ICP4 binding sites across the viral genome during infection

    • Assay for Transposase-Accessible Chromatin sequencing (ATAC-seq): Identifies regions of open chromatin to correlate with ICP4 binding and transcriptional activity

    • CUT&RUN or CUT&Tag: Provides higher resolution mapping of ICP4 and associated factors on viral chromatin

  • Protein interaction studies:

    • Co-immunoprecipitation: Identifies protein partners that interact with ICP4 during different phases of infection

    • Proximity labeling techniques (BioID, APEX): Maps the protein interaction network of ICP4 in living cells

    • Mass spectrometry analysis: Identifies post-translational modifications on ICP4 that might regulate its function

  • Functional mutant analysis:

    • Domain-specific mutations in ICP4: Assess the contributions of different functional domains to transcriptional activation versus repression

    • Time-of-addition experiments: Use inducible expression systems to introduce ICP4 at specific times during infection

    • Polymerase pause and release analysis: Measure how ICP4 affects RNA polymerase pausing and processivity on viral genes

These approaches would help resolve the apparently contradictory functions of ICP4, which acts as a repressor during immediate early infection (1-1.5 hours post-infection) and transitions to an activator role during later phases (3-6 hours post-infection) .

How do antagonistic viral proteins modulate ICP4 function?

Several viral proteins have been identified as antagonists to ICP4 function, providing an additional layer of regulation during infection:

  • Herpes Simplex IE protein ICP0:

    • ICP0 has been identified as an antagonist to the ICP4-DNA interaction

    • It may modulate ICP4 binding to specific promoters, affecting the balance of gene expression

    • This antagonism creates a regulatory circuit between immediate early proteins that fine-tunes viral gene expression

  • ORF O protein:

    • This protein has also been identified as an antagonist to ICP4-DNA interactions

    • The mechanism of this antagonism may involve direct competition for DNA binding or alteration of ICP4 protein properties

    • This antagonism suggests complex regulatory networks between viral proteins

  • VP22 tegument protein:

    • While not an antagonist, VP22 positively regulates ICP4 expression through post-transcriptional mechanisms

    • Deletion of VP22 results in decreased ICP4 protein levels despite unchanged mRNA levels

    • This relationship indicates that tegument proteins delivered during initial infection can influence immediate early protein expression

Understanding these antagonistic and cooperative relationships between viral proteins is essential for comprehending the complex regulatory networks that control viral gene expression during infection. Researchers investigating these interactions should consider utilizing protein-protein interaction assays, competitive DNA binding studies, and functional assays in viral mutants to elucidate the mechanisms and biological significance of these regulatory relationships.

What is the significance of ICP4 as a recombination hotspot for virus evolution?

The identification of ICP4 as a recombination hotspot has significant implications for the evolution and adaptation of equid herpesviruses:

  • Interspecies genetic exchange:

    • Recombination events involving ICP4 have been documented between multiple equid herpesvirus species (EHV-1 × EHV-4, EHV-1 × EHV-9, EHV-8 × EHV-1, and EHV-8 × EHV-9)

    • These events facilitate the exchange of genetic material between viruses that infect different equid species, potentially enabling cross-species transmission

    • The first documented natural interspecies recombinant in alphaherpesviruses involved the ICP4 gene region between EHV-1 and EHV-4

  • Functional consequences:

    • Recombination in ICP4 can alter transcriptional regulation patterns during infection

    • Changes in ICP4 function could affect viral replication efficiency, pathogenicity, or host range

    • Recombination may generate functional diversity in this essential regulatory protein, potentially creating variants with selective advantages

  • Evolutionary implications:

    • The high frequency of recombination events in the ICP4 gene (10 out of 14 identified recombination events) suggests that this region may be under particular selective pressure

    • Recombination may serve as a mechanism for rapid viral adaptation to changing environmental conditions or host factors

    • The preferential involvement of ICP4 suggests that diversification of transcriptional regulation may be a key driver of equid herpesvirus evolution

Understanding the molecular basis for ICP4's status as a recombination hotspot requires further research into DNA sequence features, chromatin structure, or protein interactions that might facilitate recombination in this region. Such studies would provide insights into both the mechanisms of viral recombination and the evolutionary trajectory of equid herpesviruses.

What are the major unresolved questions regarding EHV-1 ICP4?

Despite significant advances in understanding EHV-1 ICP4, several critical questions remain unresolved:

  • Structural determinants of function:

    • What specific structural features allow ICP4 to function as both an activator and repressor?

    • How do post-translational modifications alter ICP4 function throughout infection?

    • What is the complete three-dimensional structure of ICP4, particularly its interaction with different DNA sequences?

  • Recombination mechanisms:

    • Why is the ICP4 gene particularly prone to recombination compared to other viral genes?

    • What molecular mechanisms facilitate recombination in this region?

    • Do specific sequence motifs or secondary structures promote genetic exchange?

  • Regulatory networks:

    • How does ICP4 interact with the complete set of viral and cellular factors during infection?

    • What determines the transition from repressive to activating functions during infection?

    • How do antagonistic proteins precisely modulate ICP4 activity?

  • Host range determination:

    • How do variations in ICP4 sequences contribute to host specificity among equid herpesviruses?

    • Do recombination events in ICP4 facilitate cross-species transmission?

    • How does ICP4 interact with host-specific transcriptional machinery?

Addressing these questions will require interdisciplinary approaches combining structural biology, genomics, biochemistry, and cell biology to fully elucidate the complex functions of this essential viral regulatory protein.

What emerging technologies might advance ICP4 research?

Several cutting-edge technologies show promise for advancing our understanding of EHV-1 ICP4:

  • Cryo-electron microscopy (Cryo-EM):

    • May enable visualization of full-length ICP4 structure and complexes with DNA and transcriptional machinery

    • Could reveal conformational changes associated with different regulatory functions

    • May help identify structural features that promote recombination

  • Single-molecule techniques:

    • Single-molecule FRET to examine ICP4-DNA interactions in real-time

    • Optical tweezers to measure binding forces and kinetics

    • Super-resolution microscopy to visualize ICP4 distribution and dynamics during infection

  • CRISPR-based technologies:

    • CRISPRi for precise temporal control of ICP4 expression

    • CRISPR-Cas13 for targeted RNA manipulation to study post-transcriptional regulation

    • Base editing for precise introduction of point mutations in ICP4

  • Advanced sequencing technologies:

    • Long-read sequencing for improved detection of recombination events

    • Direct RNA sequencing to capture native RNA modifications

    • Single-cell approaches to examine cell-to-cell heterogeneity in ICP4 function

  • Computational approaches:

    • Advanced molecular dynamics simulations of ICP4-DNA interactions

    • Machine learning algorithms to predict recombination hotspots

    • Network analysis of regulatory interactions during infection

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.